Introduction The promotion of medicinal cannabis products presents some specific challenges given that very few such...
Home / News / Pearce IP Blog
ALL BLOGS BY
Katrina Crooks
Pharmacia’s Dynastat patent expires before injunction ordered; but validity challenge means section 19 certification is still issued
We recently reported on the decision in Pharmacia LLC v Juno Pharmaceuticals Pty Ltd [2022] FCA 92 in which the...
Interlocutory Injunction To Restrain Further Threats Of Patent Infringement Proceedings Granted In Car Park Scrap
In the first such judgment since the 1980s, Justice Moshinsky has granted an interlocutory injunction to prevent TMA...
Patent litigation in Australia just got a little cheaper
The Full Court’s refusal of leave to appeal today in Novartis AG v Pharmacor Pty Limited [2022] FCAFC 58 is good news...
The recipe for success: CSIRO launches bold new protein roadmap
In the quest for a more sustainable future, not least of all in response to the pressing issues of climate change and...
AU Budget 22-23: Highlights for Health, Pharma/Biopharma, Life Sciences & Agribusiness
In the Coalition Government’s Budget for the financial year 2022-23, it sets out the investments that it would make...
Pharmacia’s Dynastat patent valid, imminent patent expiry no reason to avoid injunction
Introduction Pharmacia LLC and Pfizer Australia Pty Ltd (together, Pharmacia) have partially succeeded at first...
High Court Puts The Brakes On Damages Recovery During Patent Term Extension
Introduction The decision of the High Court in H. Lundbeck A/S v Sandoz Pty Ltd [2022] HCA 4 (Lundbeck) last week...
Breaking News: Full Court strikes down two PTEs
On 18 March 2022, the Full Court gave highly awaited judgments in two cases[1] concerning the validity of patent term...
PTE alert: Patent Office cancellation of PTE paves the way for potential launch of generic YASMIN products
We have previously reported on a number of Federal Court decisions in 2021 invalidating patent term extensions (PTEs)...
Pfizer quest for Samsung Bioepis etanercept documents continues
Shortly before Christmas, the judgment handed down by Justice Burley on 18 November 2021 on a second preliminary...
PTE Alert (part 2): Bad Patent Term Extension Enables Generics to Avoid Preliminary Injunction in Australia
Newly appointed Justice Rofe delivered an early Christmas gift for generic and biosimilar companies in Australia in...
PTE Alert: interlocutory injunction refused in Tecfidera® dispute
In early November Pearce IP reported on a number of Federal Court decisions which appear to indicate flaws in the...
Breaking News – Parliament delivers early Christmas present for Health Care
In the last sitting of Parliament for 2021, the House of Representatives delivered the long-awaited Zimmerman Report,...
Hold onto your Hats! – Expedited Patent Litigation in Australia
The speed of getting a case to trial is a key metric of any litigation system. Pharmaceutical patent litigation often...
PTE Alert: Recent cases create fertile ground for PTE challenges
In the last year, two significant Federal Court decisions, reported here and here have exposed key flaws in the...